Spectral AI (MDAI) Third Quarter 2025 Earnings Report
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 11 2025
0mins
Source: NASDAQ.COM
- Author's Perspective: The views and opinions presented are solely those of the author.
- No Official Endorsement: The content does not necessarily reflect the views of Nasdaq, Inc.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on MDAI
Wall Street analysts forecast MDAI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MDAI is 4.50 USD with a low forecast of 3.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.890
Low
3.00
Averages
4.50
High
6.00
Current: 1.890
Low
3.00
Averages
4.50
High
6.00
About MDAI
Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. It is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Spectral AI (MDAI) Third Quarter 2025 Earnings Report
- Author's Perspective: The views and opinions presented are solely those of the author.
- No Official Endorsement: The content does not necessarily reflect the views of Nasdaq, Inc.
Continue Reading
Spectral AI Secures $7.6 Million in New Growth Funding
Funding Announcement: Spectral AI, Inc. has priced a $7.6 million offering to support the growth and development of its DeepView® System, which focuses on medical diagnostics in wound care.
Share Issuance Details: The offering includes the issuance of 4,000,000 shares of common stock at $1.90 per share, along with corresponding warrants for future exercise.
Company Commitment: Chairman J. Michael DiMaio expressed confidence in securing institutional funding, emphasizing the company's commitment to advancing the DeepView System and supporting its BARDA Project BioShield contract.
About DeepView System: The DeepView System aims to provide clinicians with immediate assessments of burn wounds' healing potential, improving patient outcomes and reducing healthcare costs through algorithm-driven insights.
Continue Reading